|
|||||
|
|
Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter,Randomized, Double-Blind,Placebo-Controlled Trial |
|
| Authors: | Pablo E. Pergola Matt Devalaraja Steven Fishbane Michel Chonchol Vandana S. Mathur Mark T. Smith Larry Lo Kurt Herzog Rahul Kakkar Michael H. Davidson |
| Affiliation: | 1.Renal Associates, P.A., San Antonio, Texas;2.Corvidia Therapeutics, Inc., Waltham, Massachusetts;3.Division of Nephrology, Department of Medicine, Donald and Barbara Zucker School of Medicine, Great Neck, New York;4.Division of Renal Medicine Disease and Hypertension, University of Colorado, Aurora, Colorado;5.Mathur Consulting, Woodside, California;6.Nephrology Associates, Augusta, Georgia;7.Pandion Therapeutics, Inc., Waltham, Massachusetts |
| Abstract: | Open in a separate window |
| Keywords: | hemodialysis anemia chronic kidney disease cardiovascular disease erythropoietin stimulating agents inflammation |